Literature DB >> 24452684

Francisella tularensis Schu S4 lipopolysaccharide core sugar and O-antigen mutants are attenuated in a mouse model of tularemia.

Jed A Rasmussen1, Deborah M B Post, Bradford W Gibson, Stephen R Lindemann, Michael A Apicella, David K Meyerholz, Bradley D Jones.   

Abstract

The virulence factors mediating Francisella pathogenesis are being investigated, with an emphasis on understanding how the organism evades innate immunity mechanisms. Francisella tularensis produces a lipopolysaccharide (LPS) that is essentially inert and a polysaccharide capsule that helps the organism to evade detection by components of innate immunity. Using an F. tularensis Schu S4 mutant library, we identified strains that are disrupted for capsule and O-antigen production. These serum-sensitive strains lack both capsule production and O-antigen laddering. Analysis of the predicted protein sequences for the disrupted genes (FTT1236 and FTT1238c) revealed similarity to those for waa (rfa) biosynthetic genes in other bacteria. Mass spectrometry further revealed that these proteins are involved in LPS core sugar biosynthesis and the ligation of O antigen to the LPS core sugars. The 50% lethal dose (LD50) values of these strains are increased 100- to 1,000-fold for mice. Histopathology revealed that the immune response to the F. tularensis mutant strains was significantly different from that observed with wild-type-infected mice. The lung tissue from mutant-infected mice had widespread necrotic debris, but the spleens lacked necrosis and displayed neutrophilia. In contrast, the lungs of wild-type-infected mice had nominal necrosis, but the spleens had widespread necrosis. These data indicate that murine death caused by wild-type strains occurs by a mechanism different from that by which the mutant strains kill mice. Mice immunized with these mutant strains displayed >10-fold protective effects against virulent type A F. tularensis challenge.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24452684      PMCID: PMC3993386          DOI: 10.1128/IAI.01640-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

1.  Novel sialic acid transporter of Haemophilus influenzae.

Authors:  Simon Allen; Anthony Zaleski; Jason W Johnston; Bradford W Gibson; Michael A Apicella
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Structural analysis of Francisella tularensis lipopolysaccharide.

Authors:  Evgeny Vinogradov; Malcolm B Perry; J Wayne Conlan
Journal:  Eur J Biochem       Date:  2002-12

3.  Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region.

Authors:  A Poltorak; I Smirnova; X He; M Y Liu; C Van Huffel; O McNally; D Birdwell; E Alejos; M Silva; X Du; P Thompson; E K Chan; J Ledesma; B Roe; S Clifton; S N Vogel; B Beutler
Journal:  Blood Cells Mol Dis       Date:  1998-09       Impact factor: 3.039

4.  Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors.

Authors:  Adeline M Hajjar; Megan D Harvey; Scott A Shaffer; David R Goodlett; Anders Sjöstedt; Helen Edebro; Mats Forsman; Mona Byström; Mark Pelletier; Christopher B Wilson; Samuel I Miller; Shawn J Skerrett; Robert K Ernst
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

5.  Structure and biosynthesis of free lipid A molecules that replace lipopolysaccharide in Francisella tularensis subsp. novicida.

Authors:  Xiaoyuan Wang; Anthony A Ribeiro; Ziqiang Guan; Sara C McGrath; Robert J Cotter; Christian R H Raetz
Journal:  Biochemistry       Date:  2006-12-05       Impact factor: 3.162

Review 6.  Tularaemia.

Authors:  A Tärnvik; L Berglund
Journal:  Eur Respir J       Date:  2003-02       Impact factor: 16.671

7.  Novel modification of lipid A of Francisella tularensis.

Authors:  Nancy J Phillips; Birgit Schilling; Molly K McLendon; Michael A Apicella; Bradford W Gibson
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

8.  Identification of an outer membrane protein required for the transport of lipopolysaccharide to the bacterial cell surface.

Authors:  Martine P Bos; Boris Tefsen; Jeroen Geurtsen; Jan Tommassen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-10       Impact factor: 11.205

Review 9.  Lipid A modification systems in gram-negative bacteria.

Authors:  Christian R H Raetz; C Michael Reynolds; M Stephen Trent; Russell E Bishop
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

10.  Francisella tularensis selectively induces proinflammatory changes in endothelial cells.

Authors:  Colin A Forestal; Jorge L Benach; Chateen Carbonara; Jaime K Italo; Tracy J Lisinski; Martha B Furie
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

View more
  12 in total

1.  Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies.

Authors:  Linxiao Chen; Jenny L Valentine; Chung-Jr Huang; Christine E Endicott; Tyler D Moeller; Jed A Rasmussen; Joshua R Fletcher; Joseph M Boll; Joseph A Rosenthal; Justyna Dobruchowska; Zhirui Wang; Christian Heiss; Parastoo Azadi; David Putnam; M Stephen Trent; Bradley D Jones; Matthew P DeLisa
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-06       Impact factor: 11.205

Review 2.  The Francisella tularensis Polysaccharides: What Is the Real Capsule?

Authors:  Kelly C Freudenberger Catanzaro; Thomas J Inzana
Journal:  Microbiol Mol Biol Rev       Date:  2020-02-12       Impact factor: 11.056

Review 3.  Multifaceted effects of Francisella tularensis on human neutrophil function and lifespan.

Authors:  Lauren C Kinkead; Lee-Ann H Allen
Journal:  Immunol Rev       Date:  2016-09       Impact factor: 12.988

4.  Metabolic Reprogramming of Host Cells by Virulent Francisella tularensis for Optimal Replication and Modulation of Inflammation.

Authors:  Elliott V Wyatt; Karina Diaz; Amanda J Griffin; Jed A Rasmussen; Deborah D Crane; Bradley D Jones; Catharine M Bosio
Journal:  J Immunol       Date:  2016-03-30       Impact factor: 5.422

5.  Interactions of Francisella tularensis with Alveolar Type II Epithelial Cells and the Murine Respiratory Epithelium.

Authors:  Matthew Faron; Joshua R Fletcher; Jed A Rasmussen; Michael A Apicella; Bradley D Jones
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

Review 6.  Uncovering the components of the Francisella tularensis virulence stealth strategy.

Authors:  Bradley D Jones; Matthew Faron; Jed A Rasmussen; Joshua R Fletcher
Journal:  Front Cell Infect Microbiol       Date:  2014-03-07       Impact factor: 5.293

7.  Evidence Suggesting That Francisella tularensis O-Antigen Capsule Contains a Lipid A-Like Molecule That Is Structurally Distinct from the More Abundant Free Lipid A.

Authors:  Jason H Barker; Justin W Kaufman; Michael A Apicella; Jerrold P Weiss
Journal:  PLoS One       Date:  2016-06-21       Impact factor: 3.240

8.  Characterization of Francisella tularensis Schu S4 mutants identified from a transposon library screened for O-antigen and capsule deficiencies.

Authors:  Jed A Rasmussen; Joshua R Fletcher; Matthew E Long; Lee-Ann H Allen; Bradley D Jones
Journal:  Front Microbiol       Date:  2015-05-05       Impact factor: 5.640

9.  A spontaneous mutation in kdsD, a biosynthesis gene for 3 Deoxy-D-manno-Octulosonic Acid, occurred in a ciprofloxacin resistant strain of Francisella tularensis and caused a high level of attenuation in murine models of tularemia.

Authors:  Taylor Chance; Jennifer Chua; Ronald G Toothman; Jason T Ladner; Jonathan E Nuss; Jo Lynne Raymond; Fabrice V Biot; Samandra Demons; Lynda Miller; Stephanie Halasohoris; Sherry Mou; Galina Koroleva; Sean Lovett; Gustavo Palacios; Nicholas J Vietri; Patricia L Worsham; Christopher K Cote; Todd M Kijek; Joel A Bozue
Journal:  PLoS One       Date:  2017-03-22       Impact factor: 3.240

Review 10.  From the Outside-In: The Francisella tularensis Envelope and Virulence.

Authors:  Hannah M Rowe; Jason F Huntley
Journal:  Front Cell Infect Microbiol       Date:  2015-12-23       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.